(1)
Pradelli, L.; Ascierto, P. [Reply to Letter to the Editor in Reference to " Clinical and Economic Evaluation of the Introduction of the Combinazion Trametinib + Dabrafenib in the Management of Advanced Melanoma in the Italian market”]. FE 2017, 18.